| Dr Kimberley Lloyd O'sullivan, MD | |
|
14 Denton Rd, Wellesley, MA 02482-6405 | |
| (781) 235-1007 | |
| (781) 235-0006 |
| Full Name | Dr Kimberley Lloyd O'sullivan |
|---|---|
| Gender | Female |
| Speciality | Plastic Surgery |
| Location | 14 Denton Rd, Wellesley, Massachusetts |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1760461917 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208200000X | Plastic Surgery | 157703 (Massachusetts) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Kimberley Lloyd O'sullivan, MD 14 Denton Rd, Wellesley, MA 02482-6405 Ph: (781) 235-1007 | Dr Kimberley Lloyd O'sullivan, MD 14 Denton Rd, Wellesley, MA 02482-6405 Ph: (781) 235-1007 |
News Archive
At today's International Solid-State Circuit Conference (ISSCC2011), imec, Holst Centre and NXP present a versatile ultra-low power biomedical signal processor, CoolBioTM, meeting the requirements of future wearable biomedical sensor systems. The biomedical signal processor consumes only 13pJ/cycle when running a complex ECG (electrocardiogram) algorithm at 1MHz and 0.4V operating voltage. This C-programmable chip is voltage and performance scalable supporting a frequency range of 1MHz up to 100MHz with an operating voltage from 0.4 to 1.2V.
An international study led by researchers from IMIM (Hospital del Mar Medical Research Institute) published in the journal Nature Communications has revealed that the intensity or efficiency of the activation of a protein called Notch, which is involved in the different phases of embryonic development, determines the fate of cells, i.e. if cells will form the aorta artery or blood (hematopoietic) stem cells. For artery cells, many Notch molecules need to be activated, whereas for hematopoietic cells many fewer are needed.
Neurologix, Inc. (OTCBB: NRGX), a biotechnology company engaged in the development of innovative gene therapies for the brain and central nervous system, announced today that the company will showcase its novel gene transfer approach to Parkinson's disease.
Vermont, the District of Columbia and Connecticut are among those planning health law-mandated marketplaces where consumers and small businesses can buy insurance - each with its own twist.
› Verified 4 days ago
Dr. Renee B O'sullivan, M.D. Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 14 Denton Rd, Wellesley, MA 02482 Phone: 781-235-1007 Fax: 781-235-0006 |